Endocrinología

Neuroendocrinology 2020;110:809–821

https://doi.org/10.1159/000506641

Neuroendocrinology 2020;110:859–867

https://doi.org/10.1159/000505548

Neuroendocrinology. 2020 Sep 24.

DOI: 10.1159/000511791

Rev Endocr Metab Disord (2020) 

Giustina, A., Barkhoudarian, G., Beckers, A. et al. Multidisciplinary management of acromegaly: A consensus. 

Published: 10 September 2020

https://doi.org/10.1007/s11154-020-09588-z

Endocrine Practice
August 2020, Vol. 26, No. 8, pp. 883-890

ABSTRACT

Objective: Suppression of testosterone secretion and/or action in transgender women using cyproterone acetate (CPA), spironolactone, or gonadotropin-releasing hormone analogues (GA) is achieved through various mechanisms. Our objective was to characterize possible differential effects of these compounds on metabolic and endocrine variables.

Neuroendocrinology 2020;110:728–739

DOI: 10.1159/000506905

Best Practice & Research Clinical Endocrinology & Metabolism

Available online 29 June 2020

https://doi.org/10.1016/j.beem.2020.101440

Endocrine Reviews 2020 August 26

Current and Future Role of Tyrosine Kinases Inhibition in Thyroid Cancer: From Biology to Therapy

Int. J. Mol. Sci. 2020, 21(14), 4951;

https://doi.org/10.3390/ijms21144951

Received: 30 June 2020 / Accepted: 10 July 2020 / Published: 13 July 2020

Malignancy risk stratification and FNA recommendations for thyroid nodules: A comparison of ACR TI-RADS, AACE/ACE/AME and ATA guidelines

American Journal of Otolaryngology
Volume 41, Issue 6, November–December 2020, 102625